Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities
L Mateu-Arrom, L Puig - Expert Review of Clinical Pharmacology, 2024 - Taylor & Francis
Introduction Psoriasis is a chronic inflammatory skin disease often associated with several
comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes …
comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes …
Use of systemic therapies for treatment of psoriasis in patients with a history of treated solid tumours: inference-based guidance from a Multidisciplinary Expert Panel
Background Patients with treated solid tumours (TSTs) are a highly heterogeneous
population at an increased risk for malignancy compared with the general population. When …
population at an increased risk for malignancy compared with the general population. When …
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors
MG Kirchhof, VH Prajapati, M Gooderham… - Dermatology and …, 2024 - Springer
Abstract Oral Janus kinase inhibitors (JAKi), a class of advanced targeted systemic therapy,
have demonstrated efficacy and safety in the treatment of moderate-to-severe atopic …
have demonstrated efficacy and safety in the treatment of moderate-to-severe atopic …
Use of Biologic Treatment in Psoriasis Patients with HIV: A Systematic Review
S Sood, R Geng, M Heung… - Journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Use of Biologic Treatment in Psoriasis Patients with HIV: A Systematic Review Use of Biologic
Treatment in Psoriasis Patients with HIV: A Systematic Review J Am Acad Dermatol. 2024 Mar …
Treatment in Psoriasis Patients with HIV: A Systematic Review J Am Acad Dermatol. 2024 Mar …